Catherine L Jensen
Overview
Explore the profile of Catherine L Jensen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
382
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jensen C, Champagne F
Parent Sci Pract
. 2012 Nov;
12(2-3):202-211.
PMID: 23162380
Mother-infant interactions in rodents can be used to explore the biological basis of postnatal parental effects. There is emerging evidence from laboratory studies that variation in early life experiences can...
2.
Moya P, Fox M, Jensen C, LaPorte J, French H, Wendland J, et al.
BMC Pharmacol
. 2011 Apr;
11:3.
PMID: 21473759
Background: The serotonin 5-HT2C receptor (5-HT2CR) is expressed in amygdala, a region involved in anxiety and fear responses and implicated in the pathogenesis of several psychiatric disorders such as acute...
3.
Pankevich D, Teegarden S, Hedin A, Jensen C, Bale T
J Neurosci
. 2010 Dec;
30(48):16399-407.
PMID: 21123586
Long-term weight management by dieting has a high failure rate. Pharmacological targets have focused on appetite reduction, although less is understood as to the potential contributions of the stress state...
4.
Fagiolini M, Jensen C, Champagne F
Curr Opin Neurobiol
. 2009 Jun;
19(2):207-12.
PMID: 19545993
A fine interplay exists between sensory experience and innate genetic programs leading to the sculpting of neuronal circuits during early brain development. Recent evidence suggests that the dynamic regulation of...
5.
Fox M, Jensen C, Murphy D
Int J Neuropsychopharmacol
. 2009 Mar;
12(8):1055-65.
PMID: 19275775
The serotonin syndrome is a potential side-effect of serotonin-enhancing drugs, including antidepressants such as selective serotonin reuptake inhibitors (SSRIs) and monoamine oxidase inhibitors (MAOIs). We recently reported a genetic mouse...
6.
Fox M, Jensen C, French H, Stein A, Huang S, Tolliver T, et al.
Psychopharmacology (Berl)
. 2008 Aug;
201(2):203-18.
PMID: 18712364
Rationale: Serotonin transporter (SERT) knockout (-/-) mice have an altered phenotype in adulthood, including high baseline anxiety and depressive-like behaviors, associated with increased baseline extracellular serotonin levels throughout life. Objectives:...
7.
A novel, putative gain-of-function haplotype at SLC6A4 associates with obsessive-compulsive disorder
Wendland J, Moya P, Kruse M, Ren-Patterson R, Jensen C, Timpano K, et al.
Hum Mol Genet
. 2007 Dec;
17(5):717-23.
PMID: 18055562
Obsessive-compulsive disorder (OCD) is a disabling neuropsychiatric illness with strong segregation data indicative of major genetic contributions. Association analyses of common functional variants of the serotonin transporter gene (SLC6A4), a...
8.
Fox M, Jensen C, Gallagher P, Murphy D
Neuropharmacology
. 2007 Sep;
53(5):643-56.
PMID: 17765930
Administration of serotonin-enhancing drugs induces a distinctive behavioral syndrome in rodents. We previously reported that mice with a targeted disruption of the serotonin transporter (SERT) display some of these behaviors...
9.
Kalueff A, Jensen C, Murphy D
Brain Res
. 2007 Aug;
1169:87-97.
PMID: 17692295
Serotonin transporter knockout (SERT-/-) mice are extensively used as a genetic model of several neuropsychiatric disorders, and consistently display anxiety-like behaviors and inactivity in different tests. To better understand how...